Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer
Clinical trial NCT00294190 · COMPLETED
Trial details
- NCT number
- NCT00294190
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2007-09-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.